|
|
|
|
203 * !
|
Tue, 8/10/2021,
1:30 PM -
3:20 PM
|
Virtual
|
|
Recent Advances in Bayesian Adaptive Designs, from Early Phase to Confirmatory Trials — Topic-Contributed Papers
|
|
Caucus for Women in Statistics, Biopharmaceutical Section, Committee on Women in Statistics
|
|
Organizer(s): Jun Yin, Mayo Clinic
|
|
Chair(s): Jun Yin, Mayo Clinic
|
|
1:35 PM
|
Design Experiences of an Adaptive Dose-Finding Study Utilizing Bayesian Model Averaging in Autoimmune Disease
Mitchell Thomann, Eli Lilly
|
|
1:55 PM
|
BOIN12: Bayesian Optimal Interval Phase I/II Trial Design for Utility-Based Dose-Finding
Ruitao Lin, The University of Texas MD Anderson Cancer Center
|
|
2:15 PM
|
A Bayesian Phase II Clinical Trial Design for Multinomial Endpoints
Rui Qin, Janssen Pharmaceuticals; Yalin Zhu, Merck & Co Inc
|
|
2:35 PM
|
Statistical Considerations for Small-Sized Clinical Trials Utilizing a Platform Setting
Feiran Jiao, FDA; Yeh-Fong Chen, FDA
|
|
2:55 PM
|
Dynamic Borrowing from a Single Prior Data Source Using the Conditional Power Prior
Jianjin Xu, Food and Drug Administration; Laura Thompson, Food and Drug Administration
|
|
3:15 PM
|
Floor Discussion
|
